Amanda B. Parris

558 total citations
22 papers, 409 citations indexed

About

Amanda B. Parris is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Amanda B. Parris has authored 22 papers receiving a total of 409 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 13 papers in Molecular Biology and 7 papers in Cancer Research. Recurrent topics in Amanda B. Parris's work include Cancer-related Molecular Pathways (9 papers), Metabolism, Diabetes, and Cancer (6 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Amanda B. Parris is often cited by papers focused on Cancer-related Molecular Pathways (9 papers), Metabolism, Diabetes, and Cancer (6 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Amanda B. Parris collaborates with scholars based in United States and China. Amanda B. Parris's co-authors include Xiaohe Yang, Qingxia Zhao, Ming Zhao, Zhikun Ma, Ying Xing, Xiaoshan Feng, Ming Zhao, Nipun Saini, Yujie Shi and Lingfei Kong and has published in prestigious journals such as PLoS ONE, Cancer Research and Scientific Reports.

In The Last Decade

Amanda B. Parris

20 papers receiving 407 citations

Peers

Countries citing papers authored by Amanda B. Parris

Since Specialization

Citations

This map shows the geographic impact of Amanda B. Parris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanda B. Parris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanda B. Parris more than expected).

Fields of papers citing papers by Amanda B. Parris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amanda B. Parris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanda B. Parris. The network helps show where Amanda B. Parris may publish in the future.

Co-authorship network of co-authors of Amanda B. Parris

This figure shows the co-authorship network connecting the top 25 collaborators of Amanda B. Parris. A scholar is included among the top collaborators of Amanda B. Parris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amanda B. Parris. Amanda B. Parris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Metformin-induced downregulation of c-Met is a determinant of sensitivity in MDA-MB-468 breast cancer cells 2022 ·Biochemical and Biophysical Research Communications ·(unknown), Amanda B. Parris, Xiaohe Yang	3
2	Abstract 1123: c-Met downregulation contributes to Metformin-induced inhibition of MDA-MB-468 triple negative breast cancer cells 2022 ·Cancer Research ·(unknown), Zhikun Ma, Amanda B. Parris, (unknown)	0
3	In Utero Exposure to Bisphenol a Promotes Mammary Tumor Risk in MMTV-Erbb2 Transgenic Mice Through the Induction of ER-erbB2 Crosstalk 2020 ·International Journal of Molecular Sciences ·Zhikun Ma, Amanda B. Parris, (unknown), Meghan B. Davis, Xia Cao, Courtney G. Woods, Xiaohe Yang	11
4	FGFR1 overexpression renders breast cancer cells resistant to metformin through activation of IRS1/ERK signaling 2020 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Yujie Shi, Zhikun Ma, Qiong Cheng, Yudan Wu, Amanda B. Parris, Lingfei Kong, Xiaohe Yang	15
5	Bisphenol AF promotes estrogen receptor-positive breast cancer cell proliferation through amphiregulin-mediated crosstalk with receptor tyrosine kinase signaling 2019 ·PLoS ONE ·Qingxia Zhao, (unknown), Amanda B. Parris, Zhikun Ma, Ying Xing, Xiaohe Yang	18
6	DMBA promotes ErbB2‑mediated carcinogenesis via ErbB2 and estrogen receptor pathway activation and genomic instability 2018 ·Oncology Reports ·Zhikun Ma, Young Kim, (unknown), Xiaoshan Feng, Stanley D. Kosanke, Shihe Yang, (unknown), Amanda B. Parris, Xia Cao, Shibo Li, Xiaohe Yang	11
7	Caloric restriction inhibits mammary tumorigenesis in MMTV-ErbB2 transgenic mice through the suppression of ER and ErbB2 pathways and inhibition of epithelial cell stemness in premalignant mammary tissues 2018 ·Carcinogenesis ·Zhikun Ma, Amanda B. Parris, (unknown), Yujie Shi, Shihe Yang, (unknown), Lingfei Kong, Xiaohe Yang	14
8	Ganetespib targets multiple levels of the receptor tyrosine kinase signaling cascade and preferentially inhibits ErbB2-overexpressing breast cancer cells 2018 ·Scientific Reports ·(unknown), Nipun Saini, (unknown), Amanda B. Parris, Zhikun Ma, Qingxia Zhao, Ming Zhao, Bolin Liu, Susan M. Edgerton, Ann D. Thor, Xiaohe Yang	20
9	The logic of imagination: a Spinozan critique of imaginative freedom 2018 ·The Institutional Repository at DePaul University (DePaul University) ·Amanda B. Parris	0
10	p53 pathway determines the cellular response to alcohol-induced DNA damage in MCF-7 breast cancer cells 2017 ·PLoS ONE ·Ming Zhao, (unknown), (unknown), Amanda B. Parris, Xiaohe Yang	20
11	FGFR inhibitor, AZD4547, impedes the stemness of mammary epithelial cells in the premalignant tissues of MMTV-ErbB2 transgenic mice 2017 ·Scientific Reports ·Qingxia Zhao, Amanda B. Parris, (unknown), Ming Zhao, Zhikun Ma, (unknown), Ying Xing, Xiaohe Yang	14
12	Short-term early exposure to lapatinib confers lifelong protection from mammary tumor development in MMTV-erbB-2 transgenic mice 2017 ·Journal of Experimental & Clinical Cancer Research ·Zhikun Ma, Amanda B. Parris, (unknown), (unknown), Stanley D. Kosanke, Xiaoshan Feng, Xiaohe Yang	8
13	Buformin inhibits the stemness of erbB-2-overexpressing breast cancer cells and premalignant mammary tissues of MMTV-erbB-2 transgenic mice 2017 ·Journal of Experimental & Clinical Cancer Research ·Amanda B. Parris, Qingxia Zhao, (unknown), Ming Zhao, Zhikun Ma, Xiaohe Yang	17
14	Activation of cancerous inhibitor of PP2A (CIP2A) contributes to lapatinib resistance through induction of CIP2A-Akt feedback loop in ErbB2-positive breast cancer cells 2017 ·Oncotarget ·Ming Zhao, (unknown), Amanda B. Parris, (unknown), Qingxia Zhao, Zhikun Ma, Ying Xing, Bolin Liu, Susan M. Edgerton, Ann D. Thor, Xiaohe Yang	15
15	Ganetespib induces G2/M cell cycle arrest and apoptosis in gastric cancer cells through targeting of receptor tyrosine kinase signaling 2017 ·International Journal of Oncology ·(unknown), Nipun Saini, Amanda B. Parris, Ming Zhao, Xiaohe Yang	29
16	Phenformin inhibits growth and epithelial-mesenchymal transition of ErbB2-overexpressing breast cancer cells through targeting the IGF1R pathway 2017 ·Oncotarget ·(unknown), Ming Zhao, (unknown), Qingxia Zhao, Amanda B. Parris, Zhikun Ma, Xiaohe Yang	21
17	Androgen receptor regulation by histone methyltransferase Suppressor of variegation 3-9 homolog 2 and Melanoma antigen-A11 2016 ·Molecular and Cellular Endocrinology ·Emily B. Askew, Suxia Bai, Amanda B. Parris, John T. Minges, Elizabeth M. Wilson	16
18	Genistein targets the cancerous inhibitor of PP2A to induce growth inhibition and apoptosis in breast cancer cells 2016 ·International Journal of Oncology ·Qingxia Zhao, (unknown), Amanda B. Parris, Ying Xing, Xiaohe Yang	44
19	Alcohol promotes migration and invasion of triple‐negative breast cancer cells through activation of p38 MAPK and JNK 2016 ·Molecular Carcinogenesis ·Ming Zhao, (unknown), Amanda B. Parris, (unknown), Qingxia Zhao, Xiaohe Yang	37
20	p53 is required for metformin-induced growth inhibition, senescence and apoptosis in breast cancer cells 2015 ·Biochemical and Biophysical Research Communications ·(unknown), Ming Zhao, Amanda B. Parris, Xiaoshan Feng, Xiaohe Yang	55

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact